Taikang Asset Management (HK)’s NovaBridge Biosciences American Depositary Shares NBP Stock Holding History

Taikang Asset Management (HK)’s Portfolio NBP Stock Details NBP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$420K	Buy	170,931 +42,166	+33%	+$141K	0.04%	72
2025 Q4	$512K	Buy	+128,765	New	+$570K	0.05%	104

Other funds holding NBP

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return

ACM

AIHC Capital Management Central $120M AUM

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Candriam SCA Strassen, Luxembourg, Luxembourg $19.3B AUM 39.18% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Taikang Asset Management (HK)'s NBP Position: Q1 2026 in Review

Taikang Asset Management (HK) increased its NovaBridge Biosciences American Depositary Shares (NBP) stake by 33% in Q1 2026, buying an estimated $141K and bringing the position to 170,931 shares worth $420K. The position accounts for 0.04% of the portfolio, ranked #72.

Taikang Asset Management (HK) first reported a position in NBP in Q4 2025 and has held it in 2 quarters since. The position peaked at $512K in Q4 2025. 48 funds tracked by Wall St. Rank hold NBP as of Q1 2026.

Taikang Asset Management (HK) held 170,931 shares of NovaBridge Biosciences American Depositary Shares worth $420K as of Q1 2026.
Taikang Asset Management (HK) bought 42,166 NovaBridge Biosciences American Depositary Shares shares in Q1 2026, an estimated $141K.
NovaBridge Biosciences American Depositary Shares made up 0.04% of Taikang Asset Management (HK)'s portfolio in Q1 2026, its #72 holding.
Taikang Asset Management (HK) first reported a position in NovaBridge Biosciences American Depositary Shares in Q4 2025 and has held it in 2 quarters since.
Taikang Asset Management (HK)'s NovaBridge Biosciences American Depositary Shares position peaked at $512K in Q4 2025.
48 funds tracked by Wall St. Rank held NovaBridge Biosciences American Depositary Shares as of Q1 2026.

Based on Taikang Asset Management (HK)'s 13F filing for Q1 2026, filed 14 May 2026.